Clinical Trials Logo

Interstitial Cystitis clinical trials

View clinical trials related to Interstitial Cystitis.

Filter by:

NCT ID: NCT05155384 Recruiting - Clinical trials for Interstitial Cystitis

Biopsychosocial and Conventional Approach in Bladder Pain Syndrome

Start date: November 12, 2021
Phase: N/A
Study type: Interventional

The aim of the present study is to compare the effects of biopsychosocial and conventional approach on symptom severity, pain parameters (pain intensity and pain cognitions), disability, psychological distress and quality of life in patients who are suffering from bladder pain syndrome/interstitial cystitis. The study is designed as a randomized clinical trial including two parallel arms. Individuals who meet the inclusion criteria and agree to participate will be randomly assigned into one of the two research arms: biopsychosocial approach group or conventional approach group. A biopsychosocial approach, which is a holistic approach that includes pain neuroscience education, relaxation training and cognitive exercises, will be applied to the patients in the first research arm for the treatment of chronic pain symptoms. For the patients in the second research arm, a conventional approach including pelvic floor stretching exercises and Transcutaneous Electrical Nerve Stimulation (TENS) will be applied for the treatment of chronic pain complaints. Treatments will be lasted for a total of six weeks, with two sessions per week. Participants will be evaluated at the baseline (before treatments) and at the end of the 6th week (after treatments). In the evaluations, information about the demographic and physical characteristics, medical and surgical background, medications and lifestyle characteristics (water, tea, coffee, alcohol, cigarette consumption, the presence constipation and physical activity level) of the individuals will be recorded. For primary or secondary outcome measures, Interstitial Cystitis Symptom and Problem Index, Visual Analog Scale, Pain Catastrophizing Scale, Pain Self-Efficacy Questionnaire, 3-day voiding diary, Pain Disability Index, Hospital Anxiety and Depression Scale, and Short Form-36 will be used. The present study is planned to be carried out with a total of 60 individuals, 30 for each study group based on a sample size analysis. After reaching required sample for the present study, in patients with bladder pain syndrome/interstitial cystitis, the effects of biopsychosocial and conventional approach on symptom and problem severity, pain parameters, disability, psychological status and quality of life will be analyzed using (2*2) two-way ANOVA.

NCT ID: NCT05149573 Recruiting - Clinical trials for Interstitial Cystitis

Investigation of PEMF Therapy for Female Patients With IC/BPS

Start date: August 29, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to gather information about the safety and effectiveness of the non-pharmacological (non-drug), non-invasive treatment known as low-frequency pulsed electromagnetic field (PEMF) therapy. The study team will distribute the PEMF device to female adults with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) to measure its ability to decrease bladder and pelvic pain as well as other urinary symptoms associated with IC/BPS. There are two sequential Aims in this study and subjects will be recruited to participate in only one Aim. In both Aims, data will be collected at baseline/enrollment, 4-weeks after using PEMF therapy, and 8, 12, and 16 weeks post-enrollment.

NCT ID: NCT05147779 Recruiting - Clinical trials for Erectile Dysfunction

Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis

Start date: September 12, 2021
Phase: Phase 1
Study type: Interventional

This trial will study the safety and efficacy of intravenous and intracavernosal or interstitial delivery of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Peyronie's disease, erectile dysfunction , and Interstitial Cystitis

NCT ID: NCT05127616 Recruiting - Chronic Pain Clinical Trials

EPPIC: Easing Pelvic Pain Interventions Clinical Research Program

EPPIC
Start date: August 10, 2022
Phase: N/A
Study type: Interventional

The EPPIC (Easing Pelvic Pain Interventions Clinical Research Program) study evaluates an ultra-brief, 4 session cognitive behavioral pain treatment transdiagnostic in design for urologic chronic pain syndrome (UCPPS) with clinical and practical advantages over existing behavioral therapies whose length and focus limits their adoption by clinicians and coverage for mechanistically similar comorbidities. A theoretically informed, practical, empirically grounded approach will systematically unpack CBT's working mechanisms, clarify for whom it works, ease dissemination, appeal to patients, providers, payers, and policy makers in the COVID-19 era favoring low resource intensity treatments, and reduce cost and inefficiencies associated with high intensity therapies whose complexity, length, and scarcity restricts uptake and impact.

NCT ID: NCT04845217 Recruiting - Clinical trials for Interstitial Cystitis

Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome

Start date: September 15, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to assess the use of peppermint oil as a treatment for Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS).

NCT ID: NCT04734847 Recruiting - Clinical trials for Interstitial Cystitis

Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome

IcBrainStim
Start date: June 1, 2021
Phase: N/A
Study type: Interventional

Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) is a common, chronic, and debilitating condition in women. Preliminary evidence suggests that IC/BPS pain can be reduced applying non-invasive repetitive transcranial magnetic stimulation (rTMS) to areas of the brain that regulate pelvic floor muscle activity. However, prior studies have examined rTMS in a very limited sample and have not examined changes in brain or pelvic floor muscle activity to determine the mechanism of rTMS for IC/BPS. This study is designed to directly address these limitations.

NCT ID: NCT04610359 Recruiting - Clinical trials for Interstitial Cystitis

Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis

Start date: October 20, 2020
Phase: Phase 1
Study type: Interventional

This study primarily aimed to evaluate the safety of human embryonic stem cell (hESC)-derived mesenchyma stem cells in interstitial cystitis.

NCT ID: NCT04118946 Recruiting - Clinical trials for Interstitial Cystitis

Platelet Enriched Plasma for Treatment of Interstitial Cystitis

Start date: March 20, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

A prospective randomized trial will be conducted aiming at evaluation the efficacy and safety of platelet enriched plasma for management of bladder pain syndrome .

NCT ID: NCT03523559 Recruiting - Clinical trials for Interstitial Cystitis

Genetic and Histopathologic Characteristics of Interstitial Cystitis

Start date: March 31, 2018
Phase:
Study type: Observational

Genetic and Histopathologic Characteristics of Interstitial Cystitis

NCT ID: NCT03468530 Recruiting - Clinical trials for Interstitial Cystitis

Therapeutic Effects of Endoscopic Ablation of Hunner Lesions in Interstitial Cystitis/ Bladder Pain Syndrome Patients

Start date: August 1, 2012
Phase:
Study type: Observational

efficacy of endoscopic ablation of Hunner lesions in patients with IC/BPS and the characteristics of HLs based on a long-term follow-up